|
IL127331A0
(en)
*
|
1998-11-30 |
1999-09-22 |
Yeda Res & Dev |
Peptide-based vaccine for influenza
|
|
AU2002223398A1
(en)
*
|
2000-08-10 |
2002-04-08 |
Tsinghua University |
A vaccine for influenza virus and its preparation
|
|
FI20031536A0
(fi)
*
|
2003-10-20 |
2003-10-20 |
Biotie Therapies Oyj |
Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
|
|
DK1692265T3
(da)
|
2003-11-04 |
2011-11-21 |
Univ Tulane |
Fremgangsmåde til hindring af en virus-celle-fusion ved hæmning af fusionsinitieringsområdets funktion i RNA-vira med klasse 1-membranfusogene envelopeproteiner
|
|
GB0716992D0
(en)
*
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
WO2006074303A2
(en)
*
|
2005-01-05 |
2006-07-13 |
Philadelphia Health And Education Corporation |
Delivery vehicles, bioactive substances and viral vaccines
|
|
MY157941A
(en)
|
2005-01-19 |
2016-08-15 |
Vaxinnate Corp |
Compositions of pathogen-associated molecular patterns and methods of use
|
|
FI20060200A0
(fi)
*
|
2005-04-20 |
2006-02-27 |
Glykos Finland Oy |
Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
|
|
MX2007015105A
(es)
*
|
2005-06-01 |
2008-03-18 |
Variation Biotechnologies Inc |
Formulacion de vacuna de influenza a base de peptido.
|
|
US7871626B2
(en)
*
|
2005-08-04 |
2011-01-18 |
St. Jude Children's Research Hospital |
Modified influenza virus for monitoring and improving vaccine efficiency
|
|
US7468187B2
(en)
*
|
2005-10-18 |
2008-12-23 |
Iowa State University Research Foundation, Inc. |
Canine influenza virus and related compositions and methods of use
|
|
WO2007051036A2
(en)
*
|
2005-10-26 |
2007-05-03 |
Protelix, Inc. |
Influenza combinatorial antigen vaccine
|
|
US9533036B2
(en)
*
|
2005-11-07 |
2017-01-03 |
Microvax, Llc |
Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
|
|
AU2006322907B2
(en)
*
|
2005-12-06 |
2012-08-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved influenza vaccine
|
|
HUE049580T2
(hu)
*
|
2006-01-27 |
2020-09-28 |
Seqirus Uk Ltd |
Hemagglutinint és mátrixfehérjéket tartalmazó, influenza elleni oltóanyagok
|
|
GB0613977D0
(en)
|
2006-02-07 |
2006-08-23 |
Peptcell Ltd |
Peptide sequences and compositions
|
|
ES2534332T3
(es)
*
|
2006-03-07 |
2015-04-21 |
Vaxinnate Corporation |
Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
|
|
US20080208486A1
(en)
*
|
2006-03-23 |
2008-08-28 |
Jari Natunen |
Integrated System, Device and Use Thereof
|
|
US8222204B2
(en)
|
2006-05-03 |
2012-07-17 |
The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC |
Influenza inhibiting compositions and methods
|
|
WO2008002663A2
(en)
*
|
2006-06-28 |
2008-01-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Immunogenic protein constructs
|
|
FI20060946A0
(fi)
*
|
2006-10-26 |
2006-10-26 |
Glykos Finland Oy |
Influenssaviruksen nukleiinihappoja ja peptidejä
|
|
EP2139908A4
(en)
|
2007-03-12 |
2011-02-16 |
Antigen Express Inc |
REMOVAL OF PROTEIN Li INVOLVED IN Li-RNAi CONSTRUCTIONS IN ANTICANCER IMMUNOTHERAPY
|
|
JP5654345B2
(ja)
|
2007-08-02 |
2015-01-14 |
ビオンドヴァックス ファーマシューティカルズ リミテッド |
多量体マルチエピトープインフルエンザワクチン
|
|
CA2721246A1
(en)
|
2008-04-18 |
2009-10-22 |
Vaxinnate Corporation |
Deletion mutants of flagellin and methods of use
|
|
CA2721800A1
(en)
|
2008-04-21 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
|
JP2011519834A
(ja)
*
|
2008-04-25 |
2011-07-14 |
インスティチュート フォー システムズ バイオロジー |
フラジェリンポリペプチドワクチン
|
|
WO2009135152A2
(en)
|
2008-05-02 |
2009-11-05 |
University Of Rochester |
Arrayed detector system for measurement of influenza immune response
|
|
WO2010144797A2
(en)
|
2009-06-12 |
2010-12-16 |
Vaccine Technologies, Incorporated |
Influenza vaccines with enhanced immunogenicity and uses thereof
|
|
WO2011005772A1
(en)
|
2009-07-06 |
2011-01-13 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
ES2573427T3
(es)
|
2009-07-06 |
2016-06-07 |
Variation Biotechnologies Inc. |
Procedimientos para preparar vesículas y formulaciones producidas a partir de las mismas
|
|
CA2840079C
(en)
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
|
WO2012097346A1
(en)
|
2011-01-13 |
2012-07-19 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
CN107296792B
(zh)
|
2011-01-13 |
2021-07-27 |
变异生物技术公司 |
囊泡及由其产生之制剂的制备方法
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
CA2840982C
(en)
|
2011-07-06 |
2022-06-07 |
Vira BITKO |
Human respiratory syncytial virus vaccine
|
|
WO2013028738A1
(en)
|
2011-08-22 |
2013-02-28 |
Nanobio Corporation |
Herpes simplex virus nanoemulsion vaccine
|
|
EP2780350B1
(en)
|
2011-11-18 |
2019-03-06 |
Variation Biotechnologies Inc. |
Synthetic derivatives of mpl and uses thereof
|
|
CA2894442C
(en)
|
2012-01-12 |
2020-01-21 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
US20150079077A1
(en)
|
2012-01-27 |
2015-03-19 |
Variation Biotechnologies, Inc. |
Methods and compositions for therapeutic agents
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|
|
KR20140099828A
(ko)
|
2013-02-05 |
2014-08-13 |
닛토덴코 가부시키가이샤 |
점막 투여용 백신 조성물
|
|
EP2762152A1
(en)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for transdermal administration
|
|
CN103961306A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
经皮给予用疫苗组合物
|
|
EP3662927A3
(en)
|
2013-02-05 |
2020-10-21 |
Nitto Denko Corporation |
Vaccine composition
|
|
RU2697443C2
(ru)
|
2013-02-05 |
2019-08-14 |
Нитто Денко Корпорейшн |
Препарат противораковой вакцины, содержащий пептид wt1, в форме ленты трансдермального введения
|
|
US10206985B2
(en)
|
2013-02-05 |
2019-02-19 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for mucosal administration
|
|
RU2014102948A
(ru)
*
|
2013-02-05 |
2015-08-10 |
Нитто Денко Корпорейшн |
Вакцинная композиция для мукозального введения
|
|
CN103961698A
(zh)
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
经皮或粘膜给予用疫苗组合物
|
|
CA2841016A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Wt1 peptide cancer vaccine composition for transdermal administration
|
|
US20140220100A1
(en)
|
2013-02-05 |
2014-08-07 |
Nitto Denko Corporation |
Vaccine composition for transdermal administration
|
|
RU2531235C2
(ru)
|
2013-02-15 |
2014-10-20 |
Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") |
Поливалентная вакцина против гриппа на основе гибридного белка
|
|
CN103901202B
(zh)
*
|
2014-04-04 |
2015-08-12 |
中国人民解放军成都军区疾病预防控制中心 |
基于共有表位甲型流感病毒抗体通用型竞争性elisa检测方法
|
|
US10925936B2
(en)
|
2014-09-03 |
2021-02-23 |
Nitto Denko Corporation |
Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
|
|
EP3189852B1
(en)
|
2014-09-03 |
2021-04-07 |
Nitto Denko Corporation |
Bisphosphonate-containing pharmaceutical vaccine composition for humoral immunity
|
|
US11278616B2
(en)
|
2015-08-06 |
2022-03-22 |
Nitto Denko Corporation |
Immunity induction promoting composition, and vaccine pharmaceutical composition
|
|
WO2018126060A1
(en)
*
|
2016-12-28 |
2018-07-05 |
Invvax, Inc. |
Influenza vaccines
|